Ronda Rippley
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Chromatin Remodeling and Cancer, Peroxisome Proliferator-Activated Receptors, CAR-T cell therapy research, Ubiquitin and proteasome pathways
Most-Cited Works
- → The Pharmacokinetics of Enalapril in Children and Infants with Hypertension(2001)56 cited
- → A multicenter study of the pharmacokinetics of lisinopril in pediatric patients with hypertension(2007)31 cited
- → Population pharmacokinetic characteristics of cemiplimab in patients with advanced malignancies(2021)28 cited
- → Metabolism and Renal Elimination of Gaboxadol in Humans: Role of UDP-Glucuronosyltransferases and Transporters(2008)23 cited
- → Effects of cellular pharmacology on drug distribution in tissues(1995)21 cited
- → A Randomized, Double-Blind, Placebo-Controlled Phase 1 Study of the Pharmacokinetics and Pharmacodynamics of REGN3918, a Human Antibody Against Complement Factor C5, in Healthy Volunteers(2018)20 cited
- → Base and Covariate Population Pharmacokinetic Analyses of Dupilumab Using Phase 3 Data(2020)19 cited
- → A Dual PPAR ??/?? Agonist Increases Adiponectin and Improves Plasma Lipid Profiles in Healthy Subjects(2006)17 cited
- → Pharmacokinetic assessment of an oral enalapril suspension for use in children(2000)15 cited
- → Fixed Dose of Cemiplimab in Patients with Advanced Malignancies Based on Population Pharmacokinetic Analysis(2021)12 cited